ENVERIC BIOSCIENCES INC (ENVB) Stock Price, Quote, News and Overview
NASDAQ:ENVB - Nasdaq - US29405E2081 - Common Stock - Currency: USD
ENVB Quote, Performance and Key Statistics
ENVERIC BIOSCIENCES INC
NASDAQ:ENVB (2/10/2025, 8:00:01 PM)
Premarket: 1.6 +0.02 (+1.27%)1.58
-0.08 (-4.82%)
The current stock price of ENVB is 1.58 USD. In the past month the price decreased by -73.8%. In the past year, price decreased by -87.32%.
ENVB Latest News and Analysis
What's going on in today's session
Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
What's going on in today's session
Stay up-to-date with the latest market trends in the middle of the day on Friday. Explore the top gainers and losers during today's session in our detailed report.
Which stocks are gapping on Friday?
Let's have a look at the gap up and gap down stocks in today's session.
These stocks are moving in today's pre-market session
Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Enveric Biosciences Inks Two Licensing Agreements With Restoration Biologics To Treat Joint Disease
Enveric's Akos Biosciences licensed its cannabinoid-COX-2 conjugate technology to Restoration Biologics for joint disease treatments, including osteoarthritis.
Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease
ENVB Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 66.84 | 824.85B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 26.55 | 372.57B | ||
| JNJ | JOHNSON & JOHNSON | 15.44 | 371.35B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 20.13 | 225.33B | ||
| MRK | MERCK & CO. INC. | 11.31 | 218.56B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.63 | 213.62B | ||
| PFE | PFIZER INC | 8.32 | 146.61B | ||
| SNY | SANOFI-ADR | 13.45 | 133.58B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 48.71 | 112.62B | ||
| ZTS | ZOETIS INC | 29.85 | 77.56B | ||
| GSK | GSK PLC-SPON ADR | 7.91 | 74.41B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 30.52 | 42.58B |
Related stock screener links
About ENVB
Company Profile
Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. The company is headquartered in Naples Florida, Florida and currently employs 7 full-time employees. The company went IPO on 2009-07-21. The firm is engaged in the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety and addiction disorders. The Company, through Psybrary has created a robust intellectual property (IP) portfolio of new chemical entities for specific mental health indications. Its lead program, the EVM201 Series, comprises synthetic prodrugs of the active metabolite, psilocin. The company is developing the first product from the EVM201 Series, EB-002, for the treatment of psychiatric disorders. The firm is also advancing its second program, the EVM301 Series, EB 003, which is an approach to the treatment of difficult-to-address mental health disorders. Within the Psybrary, it has three different types of molecules, Generation 1 (classic psychedelics), Generation 2 (pro-drugs), and Generation 3 (new chemical entities). The company has created over 1,000 novel psychedelic molecular compounds and derivatives.
Company Info
ENVERIC BIOSCIENCES INC
4851 Tamiami Trail N, Suite 200
Naples Florida FLORIDA 34103 US
CEO: David Johnson
Employees: 7
Company Website: https://www.enveric.com/
Investor Relations: https://www.enveric.com/investors/
Phone: 12393021707
ENVB FAQ
What is the stock price of ENVB?
The current stock price of ENVB is 1.58 USD.
What is the symbol for ENVERIC BIOSCIENCES INC stock?
The exchange symbol of ENVERIC BIOSCIENCES INC is ENVB and it is listed on the Nasdaq exchange.
On which exchange is ENVB stock listed?
ENVB stock is listed on the Nasdaq exchange.
Is ENVB a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ENVB, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ENVB.
Does ENVB stock pay dividends?
ENVB does not pay a dividend.
What is the Price/Earnings (PE) ratio of ENVB?
ENVB does not have a PE ratio as the earnings reported over the last twelve months were negative (-9.43).
ENVB Technical Analysis
ENVB Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ENVB. The financial health of ENVB is average, but there are quite some concerns on its profitability.
ENVB Financial Highlights
Over the last trailing twelve months ENVB reported a non-GAAP Earnings per Share(EPS) of -9.43. The EPS decreased by 76.04% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -205.75% | ||
| ROE | -249.45% | ||
| Debt/Equity | 0 |
ENVB Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to ENVB. The Buy consensus is the average rating of analysts ratings from 7 analysts.